Efficacy and safety of tanezumab in the treatment of pain from bone metastases.
2015
AbstractPatients with metastatic bone cancer report life-altering pain. Nerve growth factor is involved in pain signaling. Tanezumab, a nerve growth factor monoclonal antibody, has demonstrated efficacy in chronic pain. Placebo-controlled parent (NCT00545129; study 1003) and noncontrolled open-label
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
41
References
47
Citations
NaN
KQI